Sign in or register to see full information and data.

Studies / CAVD 454


Study information

Grant Affiliation:Haynes: B-Cell Lineage Envelope Design
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2014-05-27
Study Made Public:2016-11-01


Impact of IgG Subclass on Capacity to Mediate Neutralization of TH023.6


CAVD 454 is an immunogenicity study to characterize the neutralization of monoclonal antibodies from RV144 human clinical trial vaccine recipients.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.